Computer Aided Detection Market Scope
Computer-assisted detection (CAD) is a technique for reducing observational errors and, as a result, the rate of false negatives among clinicians analysing medical images. CAD is a technique that combines principles such as artificial intelligence (AI), computer vision, and medical image processing. Radiologists struggle to interpret digital mammography; as a result, computer-aided diagnostic (CAD) technology aids in improving radiologists' performance by enhancing sensitivity rate in a cost-effective manner. Computer aided diagnosis (CAD) is a commonly used tool in the identification and differential diagnosis of abnormalities in medical imaging. It is a currently used computerised analysis of medical pictures.
The Computer Aided Detection market study is segmented, by Application (Oncology, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer and Others) and major geographies with country level break-up.
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Research Analyst at AMA estimates that United States & Indian Players will contribute to the maximum growth of Global Computer Aided Detection market throughout the predicted period.
EDDA Technology, Inc. (United States), FUJIFILM Holdings Corporation (Japan), Hologic Inc. (United States), iCAD Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthcare Private Limited (Germany), CANON Medical Systems Corporation (Japan), IBM Corporation (United States), Riverain Technologies LLC. (United States) and Median Technologies (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are General Electric Company (United States), Shimadzu Analytical (India) Pvt. Ltd. (India), Carestream Health. (India), Hitachi Medical Systems Europe Holding AG (Switzerland), ESAOTE SPA (Italy), Narayana Hrudayalaya Ltd (India) and Karyopharm (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
AMA Research has segmented the market of Global Computer Aided Detection market by Type, Application and Region.
On the basis of geography, the market of Computer Aided Detection has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On 10th October, 2020 - Olympus Launched ENDO-AID, an AI-Powered Platform for Endoscopy System. The New AI Platform Allows for Real-Time Visualisation of Automatically Diagnosed Suspicious Lesions and Works in Conjunction with Olympus' Most Advanced Endoscopic Machine to Date, The EVIS X1.
Market Trend
- Technical Progress in Medical Industry
Market Drivers
- Prevalence of Cancer and Chronic Diseases
- High Investment in Diagnostics and Detection Technologies
Opportunities
- Growth in Healthcare infrastructure Due to Pandemic
Restraints
- Technological limitations
- Cost Concerns
Challenges
- Improper Shielding Associated with Cancer
- Fierce Competitive Pressure
Key Target Audience
Computer Aided Detection Solution Providers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others